Johnson & Johnson one-shot Covid vaccine gets go-ahead from FDA advisory panel
Vaccine, along with those from Pfizer and Moderna, should provide US with more than enough supply to vaccinate every person
The battle against Covid-19 took a major step forward on Friday as the US moved closer to distributing its first one-shot Covid-19 vaccine, after an independent expert advisory panel recommended drug regulators authorize the Johnson & Johnson vaccine for emergency use.
The authorization would be a significant boost to the Biden administration’s vaccinations plans, making Johnson & Johnson’s vaccine the third available to the public. Janssen, Johnson & Johnson’s vaccine subsidiary, told a Congressional hearing this week that it expects to deliver 20 million doses by March and a total of 100m doses before the end of June.